Current Blood Sugar Control Test Results 'I... ( Study says measurement underestimates...)

Current Blood Sugar Control Test Results 'Inaccurate'

Date:2/22/2008

Study says measurement underestimates true glucose control in hemodialysis patients

FRIDAY, Feb. 22 (HealthDay News) -- The current standard test for measuring blood sugar control in people with diabetes gives inaccurate results for people on kidney hemodialysis, a U.S. study finds.

Hemodialysis, used to treat patients with kidney failure, involves cleansing blood by circulating it through an artificial kidney machine.

This Wake Forest University Baptist Medical Center study of 307 diabetes patients -- 258 with end-stage kidney disease and 49 who didn't have kidney failure -- found that the HbA1c test underestimated true glucose control in hemodialysis patients. The report is published in the journal Kidney International.

These results suggest that the almost 200,000 diabetic hemodialysis patients in the United States who use this test may not be receiving optimal care for their blood sugar, study senior author Dr. Barry J. Freedman, a professor of internal medicine and nephrology, said in a prepared statement.

Diabetic patients on hemodialysis who believe their blood sugar levels are in the ideal range may actually have unacceptably high blood sugar levels, he noted.

"This was a surprise to the nephrology community. The test we've all come to accept as the gold standard has proven to be inaccurate in this patient population," Freedman said.

He said doctors and patients need to be aware that the HbA1c test underestimates glucose control.

This study was funded by Asahi Kasei Pharma Corp. of Japan, which makes a newer test that measures the amount of blood sugar that's reacted with albumin, a protein in the plasma. The GA (glycated albumin) test is not available in the United States.

More information

The National Kidney Foundation has more about hemodialysis.

0

GOOD

Page: 1 2
Related medicine news :

1. Wild Childs Quit Nits Offers a Safe, Natural Alternative to Current Toxic Head Lice Products
2. American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox(R) Products
3. Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI)
4. Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation
5. Synutra International, Inc. Amends August 2005 Current Report on Form 8-K and Annual Report on Form 10-K for the Fiscal Year Ended March 31, 2007
6. Physicians Want to Learn From Medical Mistakes But Say Current Error-Reporting Systems are Inadequate
7. Kenneth A. Sylvia Named as New Publisher of Current Psychiatry
8. Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i
9. ConsumerLab.com Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing
10. Kiadis Pharma Continues to Provide Rhitol to Participating Physicians During Completion of Current Clinical Study
11. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology

Post Your Comments:

Current Blood Sugar Control Test Results 'I...( Study says measurement underestimates...),Health